Overview of Expertise Areas


By using our patented technology – open flow microperfusion (OFM) - we perform preclinical ex-vivo and in-vivo studies as well as clinical studies. We investigate the pharmacokinetics (PK) and pharmacodynamics (PD) of new drugs as well as the bioequivalence (BE) of new pharmaceutical formulations at the target tissue level.

Testing of dermal products

Using our dOFM technology, we design customized test set-ups to generate reliable data as early as possible in drug development.

Testing BBB transport of neuropharmaceuticals

The use of cOFM technology allows a look beyond the blood-brain barrier (BBB) and assess concentrations and effects of neuroactive substances in the targeted brain tissue.

Bioequivalence testing of topical generics

We are designing, planning and performing studies to evaluate the bioequivalence for topical dermal generics directly in the dermis based on pharmacokinetics using our dOFM approach.

PK-PD testing of subcutaneous drugs

Our aOFM technology measures transport and effects of drugs in adipose tissue by providing direct access to the interstitial fluid of the subcutaneous adipose tissue.

Discover our most recent projects

Experience how OFM works and find out more about its individual applications in various successful projects.

Contact Us

 

Please reach out and we will answer
your questions, react to your ideas and
deal with your requirements straight away.

 

Keep in touch